A Promising Model for a Devastating Genetic Deficiency

News   Apr 24, 2017 | Original story from RIKEN

 
A Promising Model for a Devastating Genetic Deficiency
 
 
 
 

RELATED NEWS

Academic Redesigns FDA-Approved MabThera to Treat ALS

News

Researchers have redesigned a portion of the FDA-apporved MabThera for better-targeted treatment of ALS.

READ MORE

Fine-tuning CRISPR to Create Popular Mouse Models

News

Easi-CRISPR has the potential to revolutionize the speed at which mutant mouse models can be created

READ MORE

Biogen's MS Drug FAMPYRA Granted Standard Marketing Authorization in EU

News

Biogen's drug FAMPYRA improves walking for MS sufferers and has been granted standard marketing authorization.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE